Tom Alfredson - Concepedia

Author

Tom Alfredson

Roche (United States)

Also Known As

T ALFREDSON, Tom Alfredson, Tom. Alfredson

Publications

433

Citations

H-Index

Concepts

All Affiliations

Roche (United States)

About

Tom Alfredson is an author at Roche (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	108
2	Engineering	2	2	59
3	Biochemistry	1	1	43
4	Chemical Engineering	1	1	23
5	Chemistry	1	1	36

Tom Alfredson

Publications

250

Citations

H-Index

Page 1

	Year	Citations
Discovery of <i>S</i>-[5-Amino-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an Orally Bioavailable and Highly Selective Inhibitor of p38 Map Kinase David Goldstein, Tom Alfredson, J. A. Bertrand, Journal of Medicinal Chemistry	2006	64
Transport of levovirin prodrugs in the human intestinal Caco-2 cell line Fujun Li, Hong Lei, Cheng-I Mau, Journal of Pharmaceutical Sciences BiochemistryGastrointestinal PharmacologyLevovirin ProdrugsMedicineGut Barrier	2006	43
Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability Michael Brandl, Xiaoyang Wu, Marites Holper, Drug Development and Industrial Pharmacy	2008	36
Determination of compound identity by group type and class using diode-array detection in high-performance liquid chromatography Tom Alfredson, Terry L. Sheehan, Tom Lenert, Journal of Chromatography A EngineeringDiode-array DetectionGas ChromatographyMedicineOrganic Chemistry	1987	36
Evaluation of Polyethylene Oxide Compacts as Gastroretentive Delivery Systems Ravichandran Mahalingam, Bhaskara Jasti, Raj Birudaraj, AAPS PharmSciTech Chemical EngineeringEngineeringPolymer TechnologyPolymer SciencePolymer Engineering	2009	23
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning <scp><i>Off</i></scp> of <scp>AZ</scp>‐009 Eva Thijssen, Jonas M. den Heijer, David Puibert, Movement Disorders	2022	19
Formulation technologies to overcome poor drug-like properties Tom Alfredson, Max Zeller Drug Discovery Today Technologies Pharmaceutical FormulationExcipientsDrug DesignMedicinePharmaceutical Technology	2012	15
Single‐ and Multiple‐Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers Yue Huang, Susanne Ostrowitzki, George Hill, The Journal of Clinical Pharmacology Hepatitis C VirusPharmacotherapyAntiviral DrugPharmacodynamic ModelingMedicinal Chemistry	2005	14

Page 1